Chlamydia screening programs: A review of the literature. Part 1: Issues in the promotion of chlamydia testing of youth by primary care physicians

McKay, Alexander
March 2006
Canadian Journal of Human Sexuality;2006, Vol. 15 Issue 1, p1
Academic Journal
Rates of Chlamydia are highest among 15- to 24-year-old females. Often asymptomatic, untreated chlamydia can lead to Pelvic Inflammatory Disease (PID) and result in infertility, ectopic pregnancy, chronic pelvic pain, and increased susceptibility to HIV infection. Screening at risk women for chlamydia and treating those who test positive reduces the incidence of PID. This article reviews key data and research related to Chlamydia screening of youth by primary care physicians. These issues include the prevalence of chlamydia, the cost-effectiveness of chlamydia screening programs, the need to test males for Chlamydia, the discrepancy between guidelines for screening and the reality of physician screening practices as well as research on factors associated with the likelihood of physician Chlamydia screening of youth aged 15–24 and factors associated with the likelihood of physicians conducting sexual health risk assessments with their patients. The data and research reviewed in this article highlight the need for increased primary care physician Chlamydia screening of youth and identify issues that need to be addressed in interventions designed to increase and improve physician Chlamydia screening practices.


Related Articles

  • IUD Tail Unrelated to PID Risk. Klitsch, Michael // Family Planning Perspectives;Jan/Feb92, Vol. 24 Issue 1, p2 

    The article presents information on a multicenter international study which says that Pelvic Inflammatory Disease (PID) in IUD users is most likely due to contamination of the uterine cavity at the time of the IUD insertion, rather than the presence of IUD marker strings in the cervical canal....

  • Effectiveness and cost-effectiveness of a pharmacy-based screening programme for Chlamydia trachomatis in a high-risk health centre population in Amsterdam using mailed home-collected urine samples. van Bergen, Jan E. A. M.; Postma, Maarten J.; Peerbooms, Paul G. H.; Spangenberg, Arie C.; Tjen-A-Tak, Jessica; Bindels, Patrick J. E. // International Journal of STD & AIDS;Dec2004, Vol. 15 Issue 12, p797 

    In order to increase case-detection of Chlamydia trachomatis (CT) in a multicultural, low-income and high-CT-prevalence neighbourhood, a novel approach was piloted in collaboration with the pharmacy of the health centre. During a two-year period, women aged 15–29 years who collected their...

  • What is the cost of pelvic inflammatory disease and how much could be prevented by screening for chlamydia trachomatis? Cost analysis of the Prevention of Pelvic Infection (POPI) trial. Aghaizu, Adamma; Adams, Elisabeth J; Turner, Katy; Kerry, Sally; Hay, Phillip; Simms, Ian; Oakeshott, Pippa // Sexually Transmitted Infections;Jun2011, Vol. 87 Issue 4, p312 

    Objectives: To describe healthcare settings attended by women with clinical pelvic inflammatory disease (PID), to calculate the cost of a PID episode and to estimate how many cases could be prevented in London annually at current chlamydia screening levels.Methods: An...

  • Chlamydophila abortus Pelvic Inflammatory Disease. Walder, Gernot; Meusburger, Herwig; Hotzel, Helmut; Oehme, Albrecht; Neunteufel, Walter; Dierich, Manfred P.; Würzner, Reinhard // Emerging Infectious Diseases;Dec2003, Vol. 9 Issue 12, p1642 

    We report the first documented case of an extragestational infection with Chlamydophila abortus in humans. The pathogen was identified in a patient with severe pelvic inflammatory disease (PID) by sequence analysis of the ompA gene. Our findings raise the possibility that Chlamydiaceae other...

  • Pelvic Inflammatory Disease.  // New Harvard Guide to Women's Health;2004, p450 

    Presents a comprehensive women's health guide to pelvic inflammatory disease. Epidemiology of the disease; Symptoms of the disease; Diagnosis and treatment.

  • Self-reported Pelvic Inflammatory Disease in the United States, 1988. Aral, Sevgi O.; Mosher, William D.; Cates Jr., Willard // JAMA: Journal of the American Medical Association;11/13/91, Vol. 266 Issue 18, p2570 

    Deals with a study which assessed changes in the characteristics of women with self-reported pelvic inflammatory disease between 1982 and 1988 in the U.S. Methods; Results; Significance of the study.

  • Diagnosing Pelvic Inflammatory Disease. Kahn, James G.; Walker, Cheryl K.; Washington, A. Eugene; Landers, Daniel V.; Sweet, Richard L. // JAMA: Journal of the American Medical Association;11/13/91, Vol. 266 Issue 18, p2594 

    Deals with a study which examined the accuracy of existing diagnostic indicators for pelvic inflammatory disease in women, and developed guidelines for a diagnostic model. Methods; Results; Considerations in designing a diagnostic model.

  • Pelvic Inflammatory Disease.  // MMWR: Morbidity & Mortality Weekly Report;5/10/2002 Supplement RR-7, Vol. 51 Issue 18, p48 

    Discusses pelvic inflammatory disease that comprises a spectrum of inflammatory disorders of the upper female genital tract. Diagnosis consideration for the disease; Treatment for the disease; Management of sex partners.

  • Interventions for increasing chlamydia screening in primary care: a review. Ginige, Samitha; Fairley, Christopher K.; Hocking, Jane S.; Bowden, Francis J.; Chen, Marcus Y. // BMC Public Health;2007, Vol. 7 Issue 1, p95 

    Background: Despite guidelines recommending opportunistic chlamydia screening of younger women, screening rates in some countries remain low. Our aim was to review the evidence for specific interventions aimed at increasing chlamydia screening rates in primary care. Methods: A Medline search was...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics